• $3,213.00
    Market Cap
  • 0.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
-69,000
-93.63%
-1.1M
+258.61%
-302,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
-69,000
-93.63%
-1.1M
+258.61%
-302,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-239,000
-51.62%
-494,000
+2,644.44%
-18,000
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
0
N/A
Total Operating Expenses
664,000
-35.03%
1.0M
-58.81%
2.5M
N/A
Operating Profit
-664,000
-35.03%
-1.0M
-58.81%
-2.5M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-69,000
-93.63%
-1.1M
+258.61%
-302,000
N/A
Interest Income and Expense and Net
-69,000
-93.63%
-1.1M
+258.61%
-302,000
N/A
Total Nonoperating Income and Expense
-69,000
-93.63%
-1.1M
+258.61%
-302,000
N/A
Income before Taxes
-1.0M
-137.81%
2.7M
+142.86%
-6.3M
N/A
Income Taxes
N/A
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.0M
-137.81%
2.7M
+142.86%
-6.3M
N/A
Net Income from Continuing Operations Applicable to Common
-1.0M
-137.81%
2.7M
+142.43%
-6.4M
N/A
Basic EPS and Net Income
-0.03
-108.57%
0.35
+350.00%
-0.14
N/A
Diluted EPS and Net Income
-0.03
-57.14%
-0.07
-50.00%
-0.14
N/A
Basic Weighted Average Shares
31.8M
+316.20%
7.6M
-82.36%
43.3M
N/A
Diluted Weighted Average Shares
31.8M
+50.57%
21.1M
-51.24%
43.3M
N/A
Balance Sheet
Cash and Cash Equivalents
5,000
-99.30%
711,000
+75.99%
404,000
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5,000
-99.30%
711,000
+75.99%
404,000
N/A
Total Current Assets
5,000
-99.30%
715,000
+76.98%
404,000
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
5,000
-99.30%
715,000
+76.98%
404,000
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
20,000
-92.00%
250,000
-86.69%
1.9M
N/A
Total Current Liabilities
5.2M
-6.84%
5.6M
-56.40%
12.9M
N/A
Total Long-Term Debt
290,000
+1,350.00%
20,000
-99.26%
2.7M
N/A
Total Long-Term Liabilities
900,000
+718.18%
110,000
-98.38%
6.8M
N/A
Total Liabilities
5.2M
-8.63%
5.7M
-55.55%
12.9M
N/A
Retained Earnings
-65.3M
+1.59%
-64.3M
-4.03%
-67.0M
N/A
Total Stockholders Equity
-5.2M
+4.28%
-5.0M
-59.83%
-12.5M
N/A
Total Shares Outstanding
32.1M
+173.02%
11.8M
-93.66%
185.6M
N/A
Cash Flow
Cash from Operating Activities
-706,000
+1.88%
-693,000
+85.29%
-374,000
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
0
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
N/A
N/A
1.0M
+32.45%
755,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
962.32%
+919.76%
94.37%
-88.51%
821.52%
N/A
Return on Assets
-283.33%
-158.76%
482.22%
+116.35%
-2,948.48%
N/A
Return on Equity
19.89%
+164.58%
-30.79%
-151.91%
59.31%
N/A
Revenue Growth
93.63%
+136.20%
-258.61%
-523.03%
61.13%
N/A
Current Ratio
0.001
-99.21%
0.13
+306.07%
0.03
N/A
Cash Ratio
0.001
-99.21%
0.13
+303.83%
0.03
N/A
Debt-to-Equity Ratio
-0.06
+10.04%
-0.05
-85.32%
-0.37
N/A
Debt-to-Assets Ratio
62.00
+16,319.49%
0.38
-96.67%
11.34
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow